The therapeutic benefits of IPX-461 have been extensively studied in several clinical trials. These studies have shown that IPX-461 is effective in:
The development of novel PPARγ agonists with improved safety profiles may offer new therapeutic opportunities for the treatment of type 2 diabetes. Ongoing research focuses on: IPX-461